Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diastereoselective synthesis of C60/steroid conjugates.
Ruiz A, Coro J, Almagro L, Ruiz JA, Molero D, Maroto EE, Filippone S, Herranz MÁ, Martínez-Álvarez R, Sancho-García JC, Di Meo F, Suárez M, Martín N. Ruiz A, et al. Among authors: ruiz ja. J Org Chem. 2013 Apr 5;78(7):2819-26. doi: 10.1021/jo302528t. Epub 2013 Jan 31. J Org Chem. 2013. PMID: 23351060 Free article.
1H and 13C NMR spectral assignment of androstane derivatives.
Fuente A, Reyes M, Alvarez YM, Ruiz JA, Vélez H, Viñas-Bravo O, Montiel-Smith S, Meza-Reyes S, Sandoval-Ramírez J. Fuente A, et al. Among authors: ruiz ja. Magn Reson Chem. 2005 Aug;43(8):676-8. doi: 10.1002/mrc.1605. Magn Reson Chem. 2005. PMID: 15937975
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial.
Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ; ARROYO Study Investigators. Altrichter S, et al. Br J Dermatol. 2024 Feb 17:ljae067. doi: 10.1093/bjd/ljae067. Online ahead of print. Br J Dermatol. 2024. PMID: 38367194
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ; HILLIER study group†. Guttman-Yassky E, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12. J Eur Acad Dermatol Venereol. 2023. PMID: 37178404 Clinical Trial. No abstract available.
159 results